According to Zen Score, the 3 best medical distribution stocks to buy right now are:
1. Cencora (NYSE:COR)
Cencora (NYSE:COR) is the top medical distribution stock with a Zen Score of 53, which is 17 points higher than the medical distribution industry average of 36. It passed 20 out of 38 due diligence checks and has strong fundamentals. Cencora has seen its stock return 56.13% over the past year, overperforming other medical distribution stocks by 10 percentage points.
Cencora has an average 1 year
price target of $235.00, a downside of -3.94% from Cencora's current stock price of $244.64.
Cencora stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Cencora, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
2. Cardinal Health (NYSE:CAH)
Cardinal Health (NYSE:CAH) is the second best medical distribution stock with a Zen Score of 52, which is 16 points higher than the medical distribution industry average of 36. It passed 19 out of 38 due diligence checks and has strong fundamentals. Cardinal Health has seen its stock return 57.97% over the past year, overperforming other medical distribution stocks by 12 percentage points.
Cardinal Health has an average 1 year
price target of $113.17, an upside of 0.56% from Cardinal Health's current stock price of $112.54.
Cardinal Health stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Cardinal Health, 33.33% have issued a Strong Buy rating, 16.67% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 16.67% have issued a Strong Sell.
3. Henry Schein (NASDAQ:HSIC)
Henry Schein (NASDAQ:HSIC) is the third best medical distribution stock with a Zen Score of 49, which is 13 points higher than the medical distribution industry average of 36. It passed 15 out of 33 due diligence checks and has strong fundamentals. Henry Schein has seen its stock lose -5.64% over the past year, underperforming other medical distribution stocks by -51 percentage points.
Henry Schein has an average 1 year
price target of $80.11, an upside of 6.6% from Henry Schein's current stock price of $75.15.
Henry Schein stock has a consensus Buy recommendation according to Wall Street analysts. Of the 9 analysts covering Henry Schein, 33.33% have issued a Strong Buy rating, 11.11% have issued a Buy, 44.44% have issued a hold, while 0% have issued a Sell rating, and 11.11% have issued a Strong Sell.